78 related articles for article (PubMed ID: 12938264)
1. [Chemotherapy for advanced or metastatic pancreatic cancer: analysis of 43 randomized trials in 3 decades (1974-2002)].
Fung MC; Takayama S; Ishiguro H; Sakata T; Adachi S; Morizane T
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1101-11. PubMed ID: 12938264
[TBL] [Abstract][Full Text] [Related]
2. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer.
Sultana A; Smith CT; Cunningham D; Starling N; Neoptolemos JP; Ghaneh P
J Clin Oncol; 2007 Jun; 25(18):2607-15. PubMed ID: 17577041
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities of palliation in pancreatic cancer].
Di Costanzo F; Sdrobolini A; Gasperoni S
Tumori; 1999; 85(1 Suppl 1):S47-53. PubMed ID: 10235081
[TBL] [Abstract][Full Text] [Related]
4. [The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review].
Azria D; Seblain-El-Guerche C; Girard N; Hennequin C; Huguet F
Bull Cancer; 2008 Nov; 95(11):1116-30. PubMed ID: 19036684
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.
Liu GF; Li GJ; Zhao H
J Cell Biochem; 2018 Jan; 119(1):511-523. PubMed ID: 28608558
[TBL] [Abstract][Full Text] [Related]
6. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
7. Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
Aprile G; Negri FV; Giuliani F; De Carlo E; Melisi D; Simionato F; Silvestris N; Brunetti O; Leone F; Marino D; Santini D; Dell'Aquila E; Zeppola T; Puzzoni M; Scartozzi M
Crit Rev Oncol Hematol; 2017 Jul; 115():1-12. PubMed ID: 28602164
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for resectable and advanced pancreatic cancer.
Berlin JD; Rothenberg M
Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
[TBL] [Abstract][Full Text] [Related]
9. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?
Thota R; Maitra A; Berlin JD
Pancreas; 2017 Feb; 46(2):143-150. PubMed ID: 28085753
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in the pharmacological treatment of advanced pancreatic cancer.
Kulke MH
Expert Opin Investig Drugs; 2003 Jun; 12(6):983-92. PubMed ID: 12783602
[TBL] [Abstract][Full Text] [Related]
12. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.
Benson AB
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):28-34. PubMed ID: 9830622
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
Sullivan KM; Kozuch PS
Cancer J; 2012; 18(6):633-41. PubMed ID: 23187852
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab: still an option in the treatment of pancreatic cancer?
Faloppi L; Andrikou K; Cascinu S
Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
[TBL] [Abstract][Full Text] [Related]
15. Is it relevant that intra-arterial chemotherapy may be effective for advanced pancreatic cancer?
Ishikawa T
World J Gastroenterol; 2007 Aug; 13(32):4306-9. PubMed ID: 17708601
[TBL] [Abstract][Full Text] [Related]
16. Current concepts and novel targets in advanced pancreatic cancer.
Michl P; Gress TM
Gut; 2013 Feb; 62(2):317-26. PubMed ID: 23112132
[TBL] [Abstract][Full Text] [Related]
17. No standard treatment is available for advanced pancreatic cancer.
Lionetto R; Pugliese V; Bruzzi P; Rosso R
Eur J Cancer; 1995 Jun; 31A(6):882-7. PubMed ID: 7646915
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy for metastatic pancreatic adenocarcinoma.
Lawrence B; Findlay M
Ther Adv Med Oncol; 2010 Mar; 2(2):85-106. PubMed ID: 21789129
[TBL] [Abstract][Full Text] [Related]
19. Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.
Ahn DH; Ko AH; Meropol NJ; Bekaii-Saab TS
Am Soc Clin Oncol Educ Book; 2015; ():e222-7. PubMed ID: 25993177
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer.
Hoffman K; Glimelius B
Acta Oncol; 1998; 37(7-8):651-9. PubMed ID: 10050982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
